Patents by Inventor Francesca SCHIARETTI

Francesca SCHIARETTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 11628175
    Abstract: Dry powder formulations for inhalation containing a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: April 18, 2023
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi, Francesca Schiaretti
  • PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20210177866
    Abstract: Dry powder formulations for inhalation containing a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Application
    Filed: February 24, 2021
    Publication date: June 17, 2021
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio CAFIERO, Leonardo ORTENZI, Francesca SCHIARETTI
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10966991
    Abstract: Dry powder formulations for inhalation containing a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: April 6, 2021
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi, Francesca Schiaretti
  • PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20200368252
    Abstract: Dry powder formulations for inhalation containing a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Applicant: CHIESI FARMMACEUTICI S.P.A.
    Inventors: Claudio CAFIERO, Leonardo ORTENZI, Francesca SCHIARETTI
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10786450
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid is provided.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: September 29, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Cavecchi, Cristiana Merusi, Fausto Pivetti, Francesca Schiaretti
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10772896
    Abstract: Dry powder formulations for inhalation containing a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: September 15, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi, Francesca Schiaretti
  • Carrier particles for dry powder formulations for inhalation
    Patent number: 10709666
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: July 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20200163883
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • Carrier particles for dry powder formulations for inhalation
    Patent number: 10583085
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: March 10, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10350164
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, is provided.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: July 16, 2019
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Cavecchi, Cristiana Merusi, Fausto Pivetti, Francesca Schiaretti
  • NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20180333359
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Application
    Filed: May 14, 2018
    Publication date: November 22, 2018
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca SCHIARETTI, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20180325816
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid is provided.
    Type: Application
    Filed: May 9, 2018
    Publication date: November 15, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro CAVECCHI, Cristiana MERUSI, Fausto PIVETTI, Francesca SCHIARETTI
  • PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20180325815
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, is provided.
    Type: Application
    Filed: May 9, 2018
    Publication date: November 15, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro CAVECCHI, Cristiana MERUSI, Fausto PIVETTI, Francesca SCHIARETTI
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10086004
    Abstract: Dry powder formulations for inhalation containing a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: October 2, 2018
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi, Francesca Schiaretti
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20180133161
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: January 12, 2018
    Publication date: May 17, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Massimiliano DagIi ALBERI, Andrea BUSCA, Francesca SCHIARETTI
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9808422
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: November 7, 2017
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20170136035
    Abstract: Dry powder formulations for inhalation containing a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Application
    Filed: November 15, 2016
    Publication date: May 18, 2017
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio CAFIERO, Leonardo Ortenzi, Francesca Schiaretti
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20160263027
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9402825
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: August 2, 2016
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9308200
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 12, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi